Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine

BACKGROUND: Walking impairment is a hallmark of multiple sclerosis (MS). It affects > 90% of individuals over time, reducing independence and negatively impacting health-related quality of life, productivity, and daily activities. Walking impairment is consistently reported as one of the most dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Hobart, Jeremy, Ziemssen, Tjalf, Feys, Peter, Linnebank, Michael, Goodman, Andrew D., Farrell, Rachel, Hupperts, Raymond, Blight, Andrew R., Englishby, Veronica, McNeill, Manjit, Chang, Ih, Lima, Gabriel, Elkins, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328522/
https://www.ncbi.nlm.nih.gov/pubmed/30535670
http://dx.doi.org/10.1007/s40263-018-0586-5

Ejemplares similares

Ejemplares similares